• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[α1-肾上腺素能阻滞剂可多华对良性前列腺增生患者进行对症治疗对心血管疾病进程的影响]

[The effect of symptomatic therapy with the alpha 1-adrenoblocker Cardura in patients with benign prostatic hyperplasia on the course of cardiovascular diseases].

作者信息

Ukhal' M I, Ukhal' G M

出版信息

Lik Sprava. 1999 Jul(5):128-31.

PMID:10822700
Abstract

Forty-two patients with benign hyperplasia of the prostate were studied for the role of symptomatic therapy with a selective adrenoblocker Cardura in the prophylaxis of progression of such diseases of the cardiovascular system as arterial hypertension, angina pectoris. The obstructive and irritative symptomatology-related uresis has been shown to get normalized. Also recordable in the conducted investigations was an alleviation of arterial hypertension together with a noticeable decrease in the frequency and severity of attacks of angina.

摘要

对42例前列腺良性增生患者进行了研究,以探讨选择性肾上腺阻滞剂可多华进行症状治疗在预防诸如动脉高血压、心绞痛等心血管系统疾病进展中的作用。结果显示,与梗阻性和刺激性症状相关的排尿困难已恢复正常。在进行的调查中还发现,动脉高血压有所缓解,同时心绞痛发作的频率和严重程度显著降低。

相似文献

1
[The effect of symptomatic therapy with the alpha 1-adrenoblocker Cardura in patients with benign prostatic hyperplasia on the course of cardiovascular diseases].[α1-肾上腺素能阻滞剂可多华对良性前列腺增生患者进行对症治疗对心血管疾病进程的影响]
Lik Sprava. 1999 Jul(5):128-31.
2
[The incidence, features of the course, and treatment of arterial hypertension in patients with prostate hyperplasia].[前列腺增生患者动脉高血压的发病率、病程特点及治疗]
Lik Sprava. 2003(2):53-5.
3
[Cardura (doxazosin) in the treatment of prostatic adenoma].可多华(多沙唑嗪)治疗前列腺腺瘤
Lik Sprava. 1997 Sep-Oct(5):135-7.
4
[Experience in the use of doxazosin in patients with benign hyperplasia of the prostate].
Urol Nefrol (Mosk). 1998 May-Jun(3):3-5.
5
[Doksazozin "Cardura" in acute urinary retention caused by benign prostatic hyperplasia].[多沙唑嗪“可多华”治疗良性前列腺增生引起的急性尿潴留]
Urologiia. 2001 May-Jun(3):18-20.
6
Profile of doxazosin in patients with benign prostatic hyperplasia.多沙唑嗪在良性前列腺增生患者中的概况。
Scand J Urol Nephrol Suppl. 1995;168:21-7.
7
[Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes].[α1肾上腺素受体拮抗剂多沙唑嗪(可多华-辉瑞公司生产)在糖尿病患者高血压治疗中的应用]
Wiad Lek. 1998;51 Suppl 2:5-10.
8
Doxazosin: a new approach to hypertension and benign prostatic hyperplasia.多沙唑嗪:治疗高血压和良性前列腺增生的新方法。
Br J Clin Pract. 1996 Apr-May;50(3):154-63.
9
Efficacy of doxazosin in normotensive and hypertensive patients with benign prostatic hyperplasia.多沙唑嗪对血压正常和高血压的良性前列腺增生患者的疗效。
Scand J Urol Nephrol Suppl. 1995;168:29-33.
10
Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (Part One).多沙唑嗪——一种用于良性前列腺增生长期治疗的α1受体阻断剂(第一部分)
Int Urol Nephrol. 1995;27(3):311-8. doi: 10.1007/BF02564768.